We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...

Investors looking for safe havens in a dangerous market. China EV players, FedEx and Micron earnings next week.

Novo Nordisk faces formidable challenges from Eli Lilly and new rivals, but its first-mover advantage and expanded ...

Eli Lilly just scored a major win with its Phase 3 BRAVE-AA-PEDS study. The trial confirmed baricitinib's effectiveness in ...

Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Company expect ...

Eli Lilly (LLY) stock dropped by 0.22%, underperforming the S&P 500’s 0.49% gain. Over the past month, the stock has fallen 4 ...

A big dampener to Lupin’s plans would be the potential imposition of tariff on pharma products by the Trump government.

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...

Highlights,Institutional investors have adjusted their holdings in Eli Lilly and Company, with several firms increasing their ...

Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong ...